Literature DB >> 17229093

Serial neurochemical measurement of cerebrospinal fluid during the human sexual response cycle.

Tillmann H C Krüger1, Boris Schiffer, Matthias Eikermann, Philip Haake, Elke Gizewski, Manfred Schedlowski.   

Abstract

Recent studies examining the neuroendocrine response pattern underlying the human sexual response cycle revealed transient activation of the sympathoadrenal system and a substantial, long-lasting increase in plasma prolactin concentrations following orgasm in men and women. Prolactin has been discussed as being part of a feedback mechanism that signals centers in the central nervous system, such as the dopaminergic system controlling sexual arousal. To further elucidate the central role of neuropeptides, biogenic monoamines and neurotransmitters in human sexual behavior, a serial cerebrospinal fluid (CSF)-sampling technique was implemented using a previously established experimental paradigm for sexual activity in a laboratory setting. In parallel with peripheral endocrine measures, lumbar CSF was drawn via an indwelling spinal catheter during the sexual response cycle in 10 healthy males and 10 age-matched controls, and analysed for prolactin, oxytocin, biogenic monoamines and/or their metabolites as well as inhibitory and excitatory neurotransmitter concentrations. Parallel to raised peripheral sympathetic activity, norepinephrine also increased in CSF during audiovisual, masturbation-induced sexual arousal and orgasm, and remained elevated for the remainder of the session (F(4,72) = 8.79, P = 0.000). In contrast, none of the other measures, in particular prolactin and dopamine or its metabolites, reflected significant alteration. In conclusion, the human sexual response cycle is characterized by an increase in sympathetic activity in plasma and CSF, and by pronounced secretion of plasma prolactin after orgasm. However, alterations in dopaminergic or peptidergic activity are not found in lumbar CSF, possibly due to local and restricted release in diencephalic and mesencephalic brain regions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229093     DOI: 10.1111/j.1460-9568.2006.05215.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

Review 1.  Changes in pituitary function with ageing and implications for patient care.

Authors:  Johannes D Veldhuis
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

Review 2.  [Neurobiological foundations underlying normal and disturbed sexuality].

Authors:  T H C Krüger; J Kneer
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

3.  Men versus women on sexual brain function: prominent differences during tactile genital stimulation, but not during orgasm.

Authors:  Janniko R Georgiadis; A A T Simone Reinders; Anne M J Paans; Remco Renken; Rudie Kortekaas
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

4.  Gender and hormonal influences in reversible cerebral vasoconstriction syndrome.

Authors:  Mehmet A Topcuoglu; Kathleen E McKee; Aneesh B Singhal
Journal:  Eur Stroke J       Date:  2016-06-28

5.  Do rats have orgasms?

Authors:  James G Pfaus; Tina Scardochio; Mayte Parada; Christine Gerson; Gonzalo R Quintana; Genaro A Coria-Avila
Journal:  Socioaffect Neurosci Psychol       Date:  2016-10-25

6.  No evidence for prolactin's involvement in the post-ejaculatory refractory period.

Authors:  Susana Valente; Tiago Marques; Susana Q Lima
Journal:  Commun Biol       Date:  2021-01-04

7.  Mating and parenting experiences sculpture mood-modulating effects of oxytocin-MCH signaling.

Authors:  Joseph Phan; Lamees Alhassen; Allan Argelagos; Wedad Alhassen; Benjamin Vachirakorntong; Zitong Lin; Nayna Sanathara; Amal Alachkar
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

8.  Intranasal administration of oxytocin: behavioral and clinical effects, a review.

Authors:  Jan G Veening; Berend Olivier
Journal:  Neurosci Biobehav Rev       Date:  2013-05-04       Impact factor: 8.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.